Pieris Pharmaceuticals, Inc.

  • Home
  • About
  • Platform
  • Pipeline
  • Patients
  • Investors
    • Overview
    • News & Events
    • Presentations
    • Financial Results
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
    • Job Openings
  • Contact
  • News & Events

  • Overview
  • Press Releases
  • Media
  • Publications
  • IR Calendar
  • Email Alerts
May 01, 2018 8:00am EDT

Pieris Pharmaceuticals to Host First Quarter 2018 Investor Call and Corporate Update on May 10, 2018

Apr 25, 2018 8:00am EDT

Pieris Pharmaceuticals Appoints Ann Barbier, M.D., Ph.D., to its Board of Directors

Mar 09, 2018 6:00am EST

Pieris Pharmaceuticals Reports Full-Year 2017 Financial Results and Corporate Update

Mar 06, 2018 8:30am EST

Pieris Pharmaceuticals to Present at Investor Conferences in March

Feb 28, 2018 9:00am EST

Pieris Pharmaceuticals to Host Full-Year 2017 Investor Call and Corporate Update on March 9, 2018

Feb 19, 2018 8:30am EST

Pieris Pharmaceuticals to Present at the RBC Capital Markets 2018 Global Healthcare Conference

Feb 16, 2018 5:36pm EST

Pieris Pharmaceuticals Announces Closing of Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares

Feb 14, 2018 12:27am EST

Pieris Pharmaceuticals Announces Pricing of its Public Offering

Feb 13, 2018 4:01pm EST

Pieris Pharmaceuticals Announces Public Offering of Common Stock

Feb 09, 2018 6:45am EST

Pieris Pharmaceuticals and Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration

  • Previous
  • 1…
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • …24
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© 2022 Pieris Pharmaceuticals, Inc. All Rights Reserved.
Imprint Privacy Policy Disclaimer Sitemap Contact Us Manage Cookie Preferences